Table 1.

Patient Demographics

	n=95
Sex, female	73 (77%)
Age at diagnosis, years, mean ±SD	11.5 ±5.2
Age at transition, years, mean ±SD	21.5 ±2.5
Age at last follow-up, years, mean ±SD	23.7 ±3.4
Duration of follow-up, years, mean (IQ range)	12.5 (7.9–16.7)
JIA diagnosis, final
Oligo, persistent	5 (5%)
Oligo, extended	8 (8%)
Poly, seronegative	27 (28%)
Poly, seropositive	14 (15%)
Psoriatic	11 (12%)
ERA	13 (14%)
Systemic	7 (7%)
Undifferentiated	10 (11%)
Medications
NSAIDS	75 (79%)
Steroids, intraarticular	23 (24%)
Steroids, systemic	28 (29%)
DMARDS, non-biologic	85 (89%)
Biologics	67 (70%)